Company Profiles

driven by the PitchBook Platform

Delphi Genetics

Delphi Genetics
2001 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$1M LATEST DEAL AMOUNT
$1M TOTAL AMOUNT RAISED
Description

Provider of deoxyribonucleic acid engineering services. The company's technology can be used for synthetic biology, allowing successful cloning of genes and expression of recombinant proteins at a higher yield.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
Rue A. de Saint-Exupéry, 5
Gosselies
6041 Charleroi
Belgium

+32 (0)7 125 10 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Delphi Genetics’s full profile, request a free trial.

Delphi Genetics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 10-Mar-2015 $1M $1M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Delphi Genetics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
SAMBRINVEST Venture Capital Minority 000 0000 000000 0

Delphi Genetics Executive Team (6)

Name Title Board
Seat
Contact
Info
Marc Dechamps Chief Operating Officer
David Permentier Managing Director
Sophie Scohy Services Director
Cedric Szpirer Ph.D Founder, Executive & Scientific Director
Thierry Van Reeth Ph.D Manager, Scientific and Sales
You’re viewing 5 of 6 executives. Get the full list »

Delphi Genetics Board Members (1)

Name Representing Role Since Contact
Info
François Blondel Self Chairman 000 0000